STUDY 15 - Comparing Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC)

Stopped Low recruitment, lack of efficacy and increased adverse events in investigational arm.

Conditions

• Small Cell Lung Cancer

Interventions

• DRUG: Gemcitabine
• DRUG: Carboplatin
• DRUG: Etoposide
• DRUG: Hydroxychloroquine

Sponsor

University College, London